“Tom has an impressive and successful record of increasing a nonprofit’s revenue, engaging donors, and creating mission awareness,” said Prize4Life CEO and Co-Founder Avi Kremer.
Cambridge, Mass. (PRWEB) January 14, 2013
Prize4Life, a non-profit dedicated to accelerating the discovery of treatments and a cure for ALS (Amyotrophic Lateral Sclerosis, also known as Lou Gehrig’s disease) by using powerful incentives to attract new people and drive innovation, announced today the appointment of Thomas Leavitt as the organizations new Chief Development Officer.
Leavitt brings more than thirty years of development experience working with non-profit organizations as a board member and more recently in development leadership roles. At Prize4Life, he will be responsible for all fundraising programs as well as overseeing marketing and communications efforts. As a member of the management team, he will work closely with staff, Board members, donors, and all committed to advance the mission of Prize4Life. While his primary focus will be to increase and broaden revenues, Leavitt will also work to educate, inspire, and engage the community-at-large in the race to discover new treatments and a cure for ALS.
“Tom has an impressive and successful record of increasing a nonprofit’s revenue, engaging donors, and creating mission awareness,” said Prize4Life CEO and Co-Founder Avi Kremer. “He has built strong cultures of philanthropy at various Massachusetts-based organizations and we are delighted Tom has brought both his business acumen and non-profit development expertise to Prize4Life.”
“I am excited to be part of an innovative and inspiring team such as Prize4Life in the fight to beat ALS,” said Leavitt. “I look forward to develop relationships with our donors and stakeholders as well as to introduce our work to those unfamiliar with Prize4Life’s mission."
Prior to joining Prize4Life, Tom served as the Director of Development and Capital Campaign for Camp Avoda. He has held positions as a full-time development professional with Brain Tumor Society, Fenway Health, and the Alliance Theatre. Before entering the fundraising arena he was Vice President of Copytech commercial printing and in 1989 founded Arcadia Press—a commercial offset printing and digital graphics company created to predominately service the not-for-profit sector. Tom has served on the Board of Directors for organizations including New England Sinai Hospital, Horizons for Youth, Copley Society, Fenway Health, Massachusetts College of Art Foundation, Boston Ballet Overseers, Greater Boston Business Council, Camp Avoda, and Freedom House among others. He received a B.A. in English from the University of Massachusetts Honors College.
Prize4Life is a 501(c)(3) nonprofit organization whose mission is to accelerate the discovery of treatments and a cure for ALS (Amyotrophic Lateral Sclerosis, also known as Lou Gehrig's disease) by using powerful incentives to attract new people and drive innovation. Prize4Life believes that solutions to some of the biggest challenges in ALS research will require out-of-the-box thinking, and that some of the most critical discoveries may come from unlikely places. Founded in 2006 by Avi Kremer, who was diagnosed with ALS at the age of 29, Prize4Life encourages and rewards creative approaches that will yield real results for ALS patients. For more information, visit http://www.prize4life.org.